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Inflammation of the central nervous system (CNS) characterised by release of 
cytokines such as tumour necrosis factor-alpha (TNF-a) and interleukin-1 (IL-1) is an 
event that is often detrimental to neuronal cells and is thought to contribute to the 
neuronal loss observed during neurodegeneration.  
One objective of this study was to investigate the potential anti-inflammatory properties 
of kawakawa leaf extracts using in vitro model cell systems. Kawakawa leaf extracts 
anti-inflammatory properties have anecdotally been documented in traditional Maori 
medicinal practices (Rangoa). However, before this aspect could be carried out, 
experiments were undertaken to investigate the effects the kawakawa leaf extracts 
had on the growth rates of two mammalian cell lines (HeLa and THP-1 cells).  
Interestingly, the growth assays showed that the extracts to have both a stimulatory 
and inhibitory effect on cell growth. Toxicity of cells can be categorised as either 
necrotic or apoptotic cell death. In this study, HeLa cells and THP-1 cells were 
incubated under standard growth conditions with various concentrations (10 to 
100ug/ml) of Kawakawa leave extracts prepared at room temperature or 60OC.  
Growth data as seen in figures 2 and 3 typically have a long lag phase before they 
start to reach exponential growth between days 4 and 5. The extract having the largest 
stimulatory effect on HeLa cells as shown by figure 6 was 25 ug/ml at 60OC and the 
largest inhibitory effect seen on HeLa cells was seen at 50 ug/ml RT shown by figure 
6. The extract which has the largest stimulatory effect on THP-1 cells is 25 ug/ml 60OC 
as shown by figure 11 whereas the extract producing the largest inhibitory effect is 25 
ug/ml RT.   
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Apoptotic and necrotic cell death mechanisms were examined by using in vitro 
biochemistry techniques. Assessments were largely made based on biochemical 
changes of HeLa cells and THP-1 cells post treatment of Kawakawa leave extracts. 
Measurement of lactate dehydrogenase (LDH assays) in the growth media of cells 
that were shown to be growth inhibited during exposure to Kawakawa extracts 
indicated that the growth inhibition resulting from exposure to the extracts was not due 
to necrotic cell death processes. (ie that cells maintained their membrane integrity) 
When compared to the control, a lower amount of cytosolic LDH was seen in THP-1 
cell lines. However, HeLa cell lines produced a high level of cytosolic LDH which may 
be due to mycoplasma contamination. On average, Kawakawa concentrations at 
12.5ug/ml and 25ug/ml yielded less lysed cells percentage across both cell lines.  
The demonstrated cell growth inhibition was unlikely to be due to necrosis and 
because of this it was decided to see if cell death was caused by mitochondrial 
processes that would further support apoptotic cell death. The biochemical assay 
MTT indirectly measures mitochondrial dehydrogenase activity in the presence of 
kawakawa leave extracts. 
The MTT data illustrated mitochondrial impairment where HeLa cells exposed to 
Kawakawa 60OC concentrations 6.25 ug/ml and 12.5 ug/ml had the lowest average 
mitochondrial activity. THP-1 cells exposed to Kawakawa 60OC concentrations 12.5 
ug/ml and 50 ug/ml had the lowest average mitochondrial activity. 
The main results of this study include, the treatment of HeLa and THP-1 cells with 
kawakawa extracts demonstrated that cytotoxicity was not due to necrosis. The most 
interesting finding of this study is when kawakawa extracts inhibit cell growth there is 
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no increase in LDH. This is suggestive that the cellular membrane remains intact when 
exposed to the extract. 
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1.  Literature Review and Research aims   
 
This chapter presents an overview of what central nervous system (CNS) inflammation 
is and how this could be modulated by specific therapies such as anti-inflammatories. 
The impact of CNS inflammation on pathology including possible links to 
neurodegenerative diseases will be examined. Following this, the role primary glial 
cells play in CNS Inflammation is addressed. Studies having both in vitro and in vivo 
elements will be examined to further address primary microglial cells and 
inflammation. The chapter will then conclude with the intended objectives and aims for 




Inflammation is a process that involves changes in blood flow through blood vessels, 
increased capillary permeability and lastly leukocyte exudation. Changes in blood flow 
and the calibre of blood vessels occur soon after injury and depending on the extent 
of the injury progress at varying rates. Arterioles are dilated and new capillaries and 
venular beds are open in the affected area. This opening causes accelerated blood 
flow that accounts for the classic signals of heat and redness during inflammation. 
Leakage of protein rich fluid out of small blood vessels and into extravascular fluid is 
permitted by an increase in the permeability of microcirculation. This leads to the 
classic inflammation symptom of oedema (Markiewski, 2007).  
Leukocytes move to the endothelial lining of small blood vessels in a tightly packed 
manner. These leukocytes move through endothelial spaces and into extravascular 
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space. Leukocytes can then move and by a process of chemotaxis are subsequently 
pulled to the site of the injury (Cathcart, 2009). Neutrophils and macrophages in the 
area of the injury accumulate and act to neutralize foreign bodies via phagocytosis 
(Lee, 2003).  
In the past, it was believed that the central nervous system (CNS) including the brain 
was an immune privileged organ. Being an immune privileged organ means that the 
CNS was not thought to be susceptible to inflammation or immune activation. The 
CNS was thought to be unaffected by systemic inflammatory and immune responses 
however, over the span of a decade, this paradigm has been significantly revised 
(Lucas, 2006).  The responses by the brain and CNS to infection and inflammation 
exhibit different levels of responses when compared to other tissues. The largest 
difference is seen in the recruitment of leukocyte cells. This is rapid in systemic organs 
but in the brain, recruitment of leukocytes is slow. In contrast to systemic organs, the 
brain activates and recruits’ microglia cells and releases proinflammatory mediators 
such as TNFa and IL1-b. The process for inflammation activation typically occurs 
within hours after CNS trauma (Lucas, 2006).  
Inflammation is caused by trauma to the CNS as well as spinal cord injury and is 
notably one of the primary symptoms. It is important to acknowledge that inflammation 
of the CNS plays a dual role. Inflammatory reactions are typically associated with 
causing damage to neurons. The CNS can communicate with the immune system and 
utilise shared mechanisms and mediators. Immune cells like macrophages on one 
hand can secrete neuro-destructive molecules such as pro inflammatory cytokines 
TNFa and IL-1β but these cells can also produce factors which can facilitate neuro-
axonal growth, survival and plasticity. This may be a reason for inflammation resulting 
in injury but also the protection of neurons (Finn, 2013).  
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The CNS, more specifically the brain demands high levels of energy, it plays an 
important role for maintaining environmental homeostasis enabling the CNS to handle 
various metabolic demands. For typical cerebral functions, 20% of the oxygen used 
by the human body and 25% of the glucose consumed by the human body is required. 
Though the brain demands so much oxygen and glucose, it makes up a small 2% 
percent of the total body mass (Belanger, 2011).  
The main processes the brain carries out that requires such demanding energy needs 
include; maintenance and restoration of ion gradients that may have degraded due to 
signalling processes like postsynaptic and action potentials. Another process that can 
accounts for high energy demands on the brain is the recycling of neurotransmitters 
(Belanger, 2011). 
The symptoms of inflammation can be subdued by non-steroidal anti-inflammatory 
drugs (NSAIDs) such as asprin or corticosteroids like cortisone, hydrocortisone and 
prednisone. However, if left untreated, inflammation can potentially lead to pathology 
changes resulting in damage to the CNS. The CNS tightly regulates the immune 
reactions that occur inside the CNS. It does this to protect the brain from events that 
might be detrimental such as neurotoxicity and axonal damage (Fakhoury, 2015). In 
recent times, due to the side effects of prolonged treated to NSAIDs, natural remedies 
such as plant extracts are being looked to for their anti-inflammatory properties 
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1.1.2. CNS inflammation 
The CNS is characterised by the blood brain barrier (BBB) which is a physical barrier 
between the CNS and the bloodstream and is composed of endothelial cells. The BBB 
prevents the majority of molecules from passing through into the CNS. The BBB in the 
CNS helps to maintain the balance of chemicals in the CNS and it does this by forming 
a near impermeable layer. The BBB is known to participate in the inflammatory 
reaction due to the expression of molecules. One class of molecules expressed by the 
BBB are cytokines. The increase of cytokines such as TNF-α and interleukin-1 beta 
(IL-1β) during an inflammatory reaction leads to the increased permeability of the BBB 
(Huber, 2001).  
As a result of this permeability, bacteria and viruses can access brain tissue 
(Fakhoury, 2015).  The vulnerable BBB can lead to alterations of the CNS environment 
which have effects on the ionic and nutritional balance. The more permeable or the 
larger the opening of the BBB is can lead to the increasing levels of serum protein 
uptake and edema (Huber, 2001). The permeability of the BBB can be altered by 
pathological states such as Human immunodeficiency virus-1 encephalitis, multiple 
sclerosis and hypoxia or glycaemia. 
Other molecules that are expressed by the BBB are adhesion molecules, these can 
be defined as sticky cell surface molecules that have a crucial facilitative role in the 
communication and intercellular binding of cells. A further molecule that is expressed 
are serine proteases, these molecules help to regulate local inflammation  (Fakhoury, 
2015). The BBB limits the exchange of inflammatory cells as well as inflammatory 
mediators under pathological and physiological conditions (Takeshita, 2012).  
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CNS inflammation was not thought to associate within the context of SCI; it was 
thought that inflammation did not occur in the CNS. CNS inflammation is mainly 
caused by mechanical pressure including; blunt trauma, the introduction of foreign 
bodies, vibrations and chronic pressure of low intensity (Purves, 2001). Increasing 
evidence over the past decade has changed this paradigm largely due to the discovery 
of alternative anti-inflammatory monocytes. Chronic inflammation leads to a change in 
cell population such as an increase of monocytes. 
The integrity of tissue as well as the environmental cues exposed to the cells are 
supported by the extracellular matrix (ECM). The ECM is a 3 dimensional network 
composed of secreted molecules such as. The upregulation of the alternative 
mononuclear (IL-10 producing) phagocytes, instead of the typical pro inflammatory 
features is seen when tissue is damaged. Chondroitin sulfate proteoglycans (CSPGs) 
are the predominant extracellular matrix component of the glial scar (Liu et al., 2015).  
The glial scar is formed by a process termed reactive astrogliosis. Astrocytes are a 
CNS cell that respond to trauma to the CNS including infection, physical trauma, 
ischemia and neurodegenerative diseases. They react by a process called reactive 
astrogliosis and this involves the changing of molecular expression and morphology 
and in severe cases, form a scar. The glial scar is made up of multiple cellular 
components that include: reactive astrocytes, microglial, endothelial cells and 
fibroblasts as well as a basal membrane this is an extracellular matrix that forms at the 
centre of the injury (Lucas, 2006).  
The glial scar acts as a barrier for re-innervation and isolates the damaged area and 
therefore it might be an area for therapy to target. It is interesting to note the prevention 
of glial scar formation increases neuronal loss from the damaged area and can inhibit 
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the repair of the blood brain barrier (BBB). Axonal re-myelination might also be 
effected by the prevention of glial scar formation (Lucas, 2006).  
Monocyte derived cells acquire matrix degrading enzymes such as MMP13 and the 
activation of mononuclear phagocytes which produce IL-10 which is dependent on the 
expression of MMP-13. MMP-13 is a gene on chromosome 11 that codes for the 
enzyme collagenase 3. It is a member of the matrix metalloproteinase (MMP) family 
and is involved in the breakdown of extracellular matrices’ and tissue remodelling.  
MMP-13 promotes an environment where axonal regeneration is permitted by 
degrading the glial scar matrix component, regulating chondroitin sulfate proteoglycan 
CSPG and promoting glial scar resolution (Page-McCaw, 2009).  
These proteoglycans activate microglial cells and macrophages via the CD44 receptor 
directly. CD44 is a protein that is present on T cells, pre-B cells, monocytes, 
neutrophils, CNS white matter, fibroblasts, skeletal muscle, and medullary thymocytes 
(Helmut, 2003).  
CD44 is found on chromosome 11q13 where it encodes a cell surface glycoprotein 
that is involved in cell–cell interactions, cell adhesion and cell migration (Gao, 1997). 
CD44 is a receptor for hyaluronic acid. This facilitates the secretion of the neurotrophic 
factors (NTFs) by cells during the first two days of injury. NTFs are a family of 
biomolecules consisting of mainly proteins or peptides that support the growth, survival 
and differentiation of both mature and developing neurons (Razavi, 2015).   
The interaction of the glial scar formation and the neuro-inflammatory response after 
SCI is illustrated by current studies and elude to the possibility of controlling neuro-
inflammation by manipulating glial scarring (Liu et al., 2015). 
Julia Newland 1107101  
 
21 
Mononuclear cells like monocytes were thought to have the primary role to sense their 
environment and to replenish tissue macrophages and dendritic cells. Typically, 
inflammatory monocytes are equipped with a set of Toll-like receptors (TLRs) as well 
as scavenger receptors. The TLRs recognize pathogen associated molecular patterns 
(PAMPS) and can remove microorganisms, lipids and dying cells via phagocytosis 
(Mogensen, 2009).  
Inflammatory monocytes produce effector molecules such as cytokines, 
myeloperoxidase and superoxide which in turn initiates inflammation. When the 
immune system of the host is healthy and is not susceptible to infection or 
inflammatory stimuli known as a ‘steady state’ (Jiyeon Yang, 2014).  
Pro-inflammatory mediators like cytokines, reactive oxygen species, and eicosanoids 
have been shown to increase the levels of cell adhesion molecules (CAMs) including 
platelet endothelial cell adhesion molecules. CAMs can be divided into four main 
protein families Ig (immunoglobulin) superfamily (IgSF CAMs), the integrins, 
the cadherins, and the selectins. In turn, this increase in cell adhesion molecules, 
increases adhesion between leukocytes and endothelium. Therefore, the CAM-
inducing activity of proinflammatory cytokines like TNFa and IL-1 beta play an 
important role in inflammation. An over activation of CAMs is seen in a number of 
chronic and acute inflammatory conditions and has opened up another avenue for 
treatment of inflammation (Figarella-Branger, 2003).  
The inflammatory response is similar to the expression of the cytoskeletal protein Glial 
fibrillary acidic protein (GFAP).  Inflammatory cytokines such as tumour necrosis factor 
alpha (TNF-α) and interleukin-1 beta (IL-1β) are released by both microglia and 
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macrophages. Once secreted, these inflammatory cytokines can activate astrocytes 
which in turn release more inflammatory cytokines (Brahmachari, 2006).  
Appropriate levels of inflammatory responses can aid in protecting the body, however, 
it is important to control the inflammatory response to mitigate the severity of the 
consequences of CNS and neuro- inflammation. The transforming growth factor 
(TGF)-β family help to regulate various biological responses including cell growth and 
differentiation (Nagaraj, 2010).  
An important function of TGF-β is the deposition of extracellular matrix (ECM) 
components. Astrocytes can be affected by TGF-β which can lead to the secretion of 
the inhibitory ECM chondroitin sulfate proteoglycans (CSPG). In this case, the axons 
will stop extending downward once they reach the CSPG rich regions of the CNS.  To 
aid in suppressing the consequences of CNS and neuro inflammation the controlling 
of the ECM secretion is seen as an important factor (Raposo, 2014). 
Another important aspect in the process of inflammation includes activation of T 
lymphocytes. Activated T lymphocytes are seen in processes such as, inflammation, 
allergic reactions and autoimmune diseases. Interleukin – 2 is the main lymphokine 
involved in this process. Interleukin-2 lymphokines are involved in multiple intracellular 
signalling pathways that allow proliferation of activated T lymphocytes (Alberts, 2002). 
Macrophages are also a key player in the host defence, immunity and inflammatory 
responses. Macrophages are responsible for producing mediators including; 
cytokines, oxygen and nitrogen species and high levels of prostaglandin E2 upon 
induction of cyclo-oxygenase -2 (COX-2) (Bianchini, 2007; Duque, 2014).  
Inflammation has been investigated in laboratory settings and this has led to the close 
examination of cascading events involved in the inflammatory process. This 
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highlighted not only the pathological process resulting from factors applied but also it 
should be noted that there is a natural anti-inflammatory process that is active after 
inflammation has reached a peak (Purves, 2001).   
A major consequence of excessive amounts of inflammatory response is a contributor 
to secondary spinal cord injury (SCI). This includes the process of gliosis involving 
major cell types like microglia, oligodendrocyte precursors, meningeal cells, astrocytes 
and stem cells. These types of cells involved in gliosis are known to be activated by 
damage to the central nervous system (CNS). This causes a glial reaction resulting in 
the formation of a glial scar (Fawcett, 1999).  
When the glial scar forms, it brings about an environment that does not allow axons to 
regenerate and could also make cellular re-myelination unsuccessful. When damage 
to the CNS occurs, it contains oligodendrocytes and myelin debris and cells involved 
in gliosis have been shown to inhibit axon regeneration (Fawcett, 1999).  
There are other consequences of CNS inflammation including chronic psychiatric 
disorders and various neurodegenerative disorders (Lucas, 2006).  
An interesting aspect of CNS inflammation that relates to neuronal regeneration is the 
area of mitochondrial energy. Neuronal regeneration is a process seen to require a 
large amount of energy. It has been recently eluded to that when axons mature 
mitochondrial transport declines. In mature neurons, 20-30% of mitochondrial in the 
neurons are motile. This enables the mitochondrion to temporally supply ATP to 
presynaptic terminals which alters synaptic energy levels and has influences over 
ATP-dependent synaptic activities (Lin, 2015).  
A correlation between energy requirement and neuronal regeneration has recently 
been examined to investigate if enhanced metabolic requirements during regeneration 
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is needed. Recently, a study reveals that as neurons mature, more energy goes into 
controlling regrowth in injured neurons as opposed to  free moving mitochondria  
(Zhou, 2016).  
Axotomy can be defined as cutting or severing an axon this denervation is applied to 
the physiology of neurons and to examine neuronal death and survival. It can also be 
used to induce acute mitochondrial depolarisation as well as ATP depletion. As an 
effect of this, mature neuron-association increases in the protein syntaphilin (SNPD). 
This is an axonal specific mitochondria-anchoring protein that anchors mitochondria 
to microtubules found in the cytoskeleton. Mitochondria contain two membranes, an 
inner membrane and the outer membrane which form the cristae. The presence of 
mitochondria is dependent on the oxidative phosphorylation of the tissue. Neurons as 
well as cardiac and skeletal muscle have an abundance of mitochondria which leaves 
them vulnerable to energy dependant defects that result from mitochondrial 
abnormalities (Zhou, 2016).  
The enhancement of mitochondrial transport via genetic manipulation is seen to 
increase the regenerative capacity. This in turn replaces unhealthy mitochondria or 
mitochondria that might have mutations that impair mitochondrial respiratory chain 
with healthy mitochondria or mitochondria that do not have mutations impairing 
mitochondrial respiratory chain resulting in increased cellular energy. Mitochondria  In 
vivo studies involving sciatic nerve crushes and knock out mice have been 
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1.1.2.1 Inflammation of the central nervous system (CNS) and its impact on 
pathology 
 
There appears to be two outcomes of CNS inflammation it can either be resolved or 
remain unresolved. The resolution of inflammation involves the removal or reduction 
of leukocytes and debris from local inflamed areas. The resolution process is initiated 
after acute challenges by cellular pathways that biosynthesis dual acting anti-
inflammatory and pro resolution molecules such as lipoxins, resolvins and protectins. 
Inflammation must be resolved in order to mitigate the spreading of inflammation 
resulting in chronic inflammation or inflammation that causes disease (Serhan, 2008).  
This section will elude to CNS pathology changes that are caused or catalysed by the 
unresolved inflammation of the CNS. Neuro diseases can be divided into two sub-
categories, acute CNS diseases and chronic CNS diseases. 
The role inflammation of the CNS after trauma plays is still under large debate. It has 
been reported that inflammation is detrimental to CNS neurons while on the other 
hand, the same inflammation has been reported to play a positive role that promotes 
CNS regeneration (Mietto, 2015).  Cytokines such as TNFa and IL-1 released by CNS 
inflammation are largely involved in neuronal loss during acute and chronic 
neurodegenerative disease. However, these cytokines may have a dual role as they 
are also seen to promote repair and recovery.  
Within a few hours following trauma to the CNS a secondary cascade of events takes 
place. This is defined by normal blood flow interruption causing poor oxygenation 
leading to haemorrhage, secondary spinal cord injury complications also include 
edema (swelling) and inflammation. The release of extracellular matrix molecules 
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including both pro and anti-regenerative factors are also harmful to the spinal cord, 
another identifier of secondary complications to spinal cord injuries is the activation of 
programmed cell death known as apoptosis (Mietto, 2015).   
Microglial cells are the first in response to various neuro-pathologies such as; 
Ischemia, chronic pain, Alzheimers disease, Parkinson’s disease, multiple sclerosis, 
amyotrophic lateral sclerosis, Huntingtons disease and brain tumours. Because of 
such involvement in various neuro-pathologies, it has become an area of interest to 
study microglial mechanisms (Fakhoury, 2015). 
Affected neurons in neurodegenerative diseases are found to share pathological signs 
that are normally found to be in axons that have had traumatic injury. The 
pathophysiology of spinal cord injuries (SCI) includes an initial evet that causes 
neuronal cell death and interrupts axonal connections. The neuron is broken down into 
two areas, the distal and proximal stumps. The distal stump of the long axon 
undergoes a degenerative process wallerian degeneration (WD) and the proximal 
stump is known to retract causing the surviving cell bodies to be more susceptible to 
subsequent secondary events (Mietto, 2015). 
WD is defined as a multi-complex phenomenon that is found to occur within the distal 
portion of injured nerves. Distal nerves change in morphology after being cut. WD was 
a term that originally describes axotomized peripheral nerves. WD is known to occur 
in both central and peripheral axons that have become separated from their parental 
cell body. WD can be triggered by traumatic injury but it also occurs in various 
neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease 
(Mietto, 2015).  
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There is increasing evidence that neurodegenerative diseases like multiple sclerosis 
(MS), Parkinson’s disease (PD) and Alzheimer’s disease (AD) are found to have high 
associations with immune system activation and neuro-inflammation. A variety of 
immunological cells are expressed during neurodegeneration (Fakhoury, 2015).  
Cytokines such as TNFa and IL-1B are secreted by macrophages and have the crucial 
role of repairing processes in the CNS by getting rid of pathogens and they help to 
reduce the severity of tissue damage. Macrophages eliminate pathogens by the 
process phagocytosis, the engulfing of bacteria or other material by phagocytes (Lee, 
2003).  
Microglia and astrocytes also participate in the active immune defence. The cells play 
a crucial part in regulating tissue homeostasis and also help to preserve the structures 
and functions characteristic of the brain (Fakhoury, 2015). Chronic activation of 
microglia (this will be addressed further on) has been seen to cause neuronal damage 
due to its direct participation in releasing cytotoxic molecules such as reactive oxygen 
species (ROS), nitric oxide (NO), and a variety of proinflammatory cytokines such as 
TNFa and IL-1B. Activated microglial produce several chemokines such as 
macrophage inflammatory protein-1 (MIP-1), monocyte chemotactic protein-1 (MCP-
1), these chemokines actively migrate microglia to the injury site and are known to 
actively participate in the amplification of brain inflammation (Fakhoury, 2015).  
Trauma and disease to the CNS can either be acute or chronic by nature:  
Acute neuro disease includes stroke and cerebral ischaemia, brain trauma , and can 
range through to epilepsy (Fakhoury, 2015).  
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Stroke and cerebral ischaemia:  
In the western world, stroke is seen as being in the top three leading causes of death 
as well as one of the leading causes of permanent disability (Fakhoury, 2015).  
Chronic CNS diseases range from multiple sclerosis (MS), Alzheimer’s disease (AD) 
and Parkinson’s disease (PD). These chronic CNS diseases are more complex in 
nature when compared to acute neuro diseases (Fakhoury, 2015).  
Multiple sclerosis (MS) 
MS typically appears in adults in their late 20s or early 30s and causes depression in 
more than 50% of the cases. This disease affects more than 2.5 million people in North 
America and Europe (Fakhoury, 2015).  
MS is described as a chronic disorder where inflammation plays a key role. The CNS 
becomes invaded with T cells and macrophages which leads to the death of myelin 
sheaths that surround axons. This leads to loss of neuronal function and death. MS 
effects many areas of the CNS and because of this, the clinical symptoms are 
heterogeneous in nature and can vary widely. Clinical symptoms of MS include fatigue, 
muscle weakness, areas of numbness and paralysis. The disease is noted to be 
progressive by cycles of relapse that can be associated with systemic infection and 
inflammation as well as remission (Lucas, 2006). 
It has been suggested by several studies that MS is a disease mediated by 
inflammation in which the immune system plays a central role. Multiple 
pharmacotherapies such as glatiramer acetate, natalizumab and mitoxantrone are 
proven therapies that help to reduce the symptoms of MS. Most of these medications 
however could cause unwanted side effects including skin irritation, liver damage and 
hypertension. Because of this, new treatment and strategies must be developed to 
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better treat MS. More models that include genetic, vial and immune related 
components need to be developed in order to further understand the pathology of the 
disease as well as identify possible targets for treatment (Fakhoury, 2015).      
Alzheimer’s disease (AD) 
AD affects individuals over the age of 65 and it is the most common neurodegenerative 
disease that develops more commonly in woman than men. AD can be characterised 
by progressive inability the patient has to form new memories as well as the increasing 
inability to access existing memories.  This is largely due to neuronal death in the 
hippocampus and frontal cortex. Once activated, microglia surround amyloid plagues, 
amyloid plagues are one of the hallmarks that characterises AD (Fakhoury, 2015; 
Lucas, 2006).  
Having been activated by the amyloid peptide, microglia cells then initiate a cascade 
of events. They synthesise and release proinflammatory cytokines (IL- 1, IL-6 and 
TNF-α) and chemokines. This typically leads to the migration of specific cells like 
monocytes across the blood brain barrier. Higher levels of these released cytokines 
have been found in the cerebral spinal fluid (CSF) of AD patients. Proinflammatory 
cytokines TNF-α and IL –I can increase the expression of the amyloid precursor 
protein and the ab peptide. This is suggestive that the inflammation in the CNS plays 
a role in amplifying the disease state of AD (Fakhoury, 2015; Lucas, 2006). 
Currently, there is no cure for AD and pharmaceuticals and psychological interventions 
are relied on by patients to reduce some of the symptoms of AD. There is strong 
evidence for the association AD has with inflammation as well as increased activation 
of the immune system. The production of beta-amyloid protein is boosted by the 
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activation of microglial and astrocytes triggered by an inflammatory response 
(Fakhoury, 2015; Lucas, 2006).   
There have been various animal models that are being used to examine pathogenic 
as well as neurogenic mechanisms of AD. AD can be induced via in vivo models by 
injecting chemical compounds or pharmaceutical agents directly into the brain. A study 
has demonstrated that intracerebroventricular infusion of beta-amyloid peptides into 
the rat could result in progressive brain dysfunction as well as neurological damage 
that is typically seen in AD patients (Fakhoury, 2015; Lucas, 2006).  
Parkinson’s disease (PD) 
PD is the most frequent neurodegenerative disease between the age of 50 and 60 and 
there is strong evidence suggesting PD is associated with neurodegeneration of 
neurons caused by CNS inflammation. Immunological activation as well as 
inflammatory processes are demonstrated to play roles in influencing the severity 
including pathogenesis and progression of PD. In PD, microglial cells are activated by 
peripheral inflammation and these cells then mediate the neurodegeneration of 
neurons in the substantia nigra. PD patients have significantly higher levels of specific 
proinflammatory cytokines for example, IL-1B, TNF-α, and interleukin – 2 (IL-2) as well 
as higher amounts of CD4, CD8 and T lymphocytes. The higher levels of these 
cytokines indicate that inflammation is increased and an activated immune response 
is seen (Fakhoury, 2015).  
Various animal models currently are used to study the pathophysiology of PD, they 
have been useful models for providing understanding of the molecular mechanisms 
that are involved in PD. One widely used neurotoxin animal models is the 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mouse model. This model is 
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designed to mimic the biochemical changes occurring throughout PD. MPTP targets 
involved neurons in PD and causes cellular apoptosis to dopaminergic cells located in 
the substancia nigra. MPTP also interferes with mitochondrial respiration that can 
result in cytotoxic consequences. Other in vivo models include the 6-hydroxydopamine 
(6-OHDA) rat model that typically targets dopaminergic pathways located in the 
substancia nigra (Fakhoury, 2015; Lucas, 2006).  
PD is typically characterised by loss of dopaminergic neurones in the substantia nigra, 
and motor symptoms of tremors, muscle rigidity and bradykinesia. PD is found to have 
an association with genetic mutations found to encode a-synuclein and parkin. PD is 
otherwise sporadic, where various environmental factors ranging from pesticides to 
infections may also contribute to the disease. In patients with PD, inflammation is seen 
to play a role where activated microglia are found in close proximity to degenerating 
substantia nigral neurons (Lucas, 2006).   
Chronic CNS diseases are typically multi-factorial with environmental factors and 
genetic backgrounds both contributing to the severity of the disease. These factors 
can also contribute to inflammation of the CNS and can be further catalysed by ageing. 
Inflammatory mediators like activation of microglia which in turn produces pro 
inflammatory cytokines, superoxide radicals NO and components of the complement 
system. These inflammatory modulators are seen to increase in chronic neuro-
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1.1.3 The role of microglial cells in CNS Inflammation  
 
To further understand the inflammatory mechanisms and pathophysiology of the 
central nervous system, it is necessary to study the role microglia have in propagating 
or at times attenuating pro-inflammatory cascades in the brain (Brawek, 2013; Mietto, 
2015). The inflammatory response has many key players involved in the reaction but 
the microglia are known as the resident immune cells in the CNS. Microglial play a 
critical role in the inflammatory response occurring in the brain. Microglial cells 
respond to stimuli from various sources resulting in producing a variety of inflammatory 
cytokines like TNF-α and IL-1β (Serhan, 2008). 
Primary glial cells can be defined as the supporting cells of the central nervous system 
and they do not conduct electrical impulses unlike neurons. The glial cells surround 
neurons and provide support for insulation between them. Glial cells are the most 
abundant cell types in the central nervous system (Purves, 2001).  
The total cellular population of the mammalian brain comprises of approximately 12% 
microglia cells (Tamashiro, 2012). Despite neurons and astrocytes being the major 
cell types of the nervous system, microglia cells play a significant role in the normal 
brain physiology by monitoring tissue for debris and pathogens and maintaining 
homeostasis in the parenchyma via phagocytic activity. The activation of microglia 
cells occur by various injury and disease conditions this includes neurodegenerative 
disease, traumatic brain injury and infection of the nervous system (Tamashiro, 2012). 
Microglia are cells that go under various names such as mononuclear phagocytes and 
these cells are specialised phagocytic cells that survey and populate the central 
nervous system during the embryonic development. Microglia are known for their 
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ability they have to scan the environment with elaborate mobile processes. Microglia 
is a type of cell that is known for a rapid responsive reaction to inflammation and injury 
(Ravikumar, 2014).  
Microglia reside in tissue as well as the infiltration of blood-borne macrophages and 
are activated by the neuro-inflammatory response. This activation further contributes 
to the secondary damage of the spinal cord, as well as the glial scar and progressive 
cavitation. The specialised blood spinal cord barrier is typically a monolayer however 
in the acute stages of a SCI it splits into two layers. An inner endothelial basement 
membrane and an outer parenchymal basement membrane. Mononuclear phagocytes 
gather within the space created by the membranes and they infiltrate into the 
surrounding parenchyma. The infiltrating monocytes exert an inflammatory cascade 
which occurs during the subacute period following the SCI. This coincides with the 
formation of the glial scar and glial limitans which could suggest that glial scar aids in 
regulating the inflammatory reaction (Ravikumar, 2014). 
Microglia under various activating conditions these cells increase phagocytic activity, 
go through morphological and proliferative changes. Microglia can also secrete 
reactive oxygen and nitrogen species, pro inflammatory cytokines, this can quite often 
activate the paracrine or the autocrine loop. Microglial activation and response from 
these cells can contribute to disease pathogenesis in neurological conditions, making  
research into the mechanisms and environment of microglia cells of large interest 
(Tamashiro, 2012).  
Microglial derive from early embryonic myeloid-monocytic cells that colonise the brain. 
These cells constantly monitor their micro-environment and can be associated with 
neuro-plasticity, host defence, homeostasis, wound healing, debris scavenging, 
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peripheral immune cells recruitment and immune response regulation. As a response 
to a range of stresses upon these cells, they have migratory capabilities and have the 
potential to undergo morphological and functional changes (Ginhoux, 2013). 
Due to the fact that microglial cells are major immune-competent cells in the brain 
microglial cells are highly involved in neuroprotection as well as neuro-degeneration. 
Microglia support the survival of neurons from the secretion of growth factors and anti-
inflammatory cytokines such as transforming growth factor beta, interleukin (IL)-1 
receptor antagonist.  While microglial are beneficial, they can become harmful if 
exposed to inappropriate pro inflammatory activity. Through secretion, microglial can 
release neurotoxins like cytokines and chemokines that are pro inflammatory and pro 
apoptotic in nature. Such neurotoxins include, IL-1B, IL-6, IL12 and tumour necrosis 
factor alpha (TNF-α). Microglial cells can also be harmful through the production of 
excitatory amino acids, eicosanoids, reactive oxygen species and nitric oxide (NO) 
(Rubio-Perez, 2012).  
1.1.3.1 Other cell types involved with CNS and neuro-inflammation  
 
As well as microglial cells, inflammation of the CNS is caused by multiple cell types 
that react to CNS trauma and as a result cause inflammation of the CNS.  
The types of CNS cells that can be observed include, oligodendrocytes, astrocytes, 
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1.1.4 The use of anti-inflammatory agents to treat CNS inflammation  
 
There is abundant data suggesting inflammation contributes to many CNS diseases 
and because of this, inflammation is becoming a target for future therapy. The potential 
for both beneficial and harmful effects yield complications when developing 
inflammatory therapies. The detrimental effects seen in the application of therapies 
may be avoided when applied to acute disease like stroke. This is because the 
application of the treatment can be applied over a short time period. Conversely, the 
application of treatment to chronic disorders presents a greater challenge (Lucas, 
2006).  
 
1.1.4.1 Anti-inflammatories  
 
This section will demonstrate how the use of anti-inflammatory agents can hope to 
mitigate the effects of CNS inflammation. This is demonstrated by both in vitro and in 
vivo models. The advantages and disadvantages of in vitro and in vivo models will 
also be addressed. 
One way that could mitigate or slow down inflammatory reactions to CNS trauma and 
injury is to investigate compounds that have possible anti-inflammatory properties.  
The use of a novel inflammatory on inflammation seen in the severed CNS is not a 
new idea. There have been studies conducted to varying degrees of success that use 
a range of compounds that illustrate and exhibit anti-inflammatory properties. For 
example, a recent study investigates the use of curcumin for improving neural function 
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after spinal cord injury by joining intracellular and extracellular components of the glial 
scar (Yuan et al., 2015) . This study established a spinal cord injury model by using 
female Sprague-dawley rats. In this model, the spinal cord was exposed and dissected 
by blunt dissection. The study sorted the rats into specific groups that included, a sham 
group, a simple injury group, the curcumin treatment group and the 
methylprednisolone (MP) treatment groups (Yuan et al., 2015).  
The methods of this study (Yuan et al., 2015) included behavioural assessment, 
Immunohistochemical analysis, western blot assays, enzyme-linked immunosorbent 
assay, real time polymerase chain reaction. The study detected intracellular and 
extracellular components of glial scar as well as related cytokines that included tumour 
necrosis factor (TNF)-a, interleukin (IL)-1b, nuclear factor (NF)-kb, transforming 
growth factor (TGF)-β1, TGF-Β2 and gender determining regions like the Y- box 
(SOX)-9.  
The results from this study found that curcumin did inhibit the expression of cytokines 
with proinflammatory properties like TNF-α, IL-1b and NF-kb (Yuan et al., 2015).  
Curcumin was also found to reduce the expression of intracellular components like 
glial fibrillary acidic protein via anti-inflammation, it also was found to suppress reactive 
gliosis. Curcumin inhibited the generation of TGF-Β1, TGF-Β2 and SOX-9 and 
decreased the deposition of chondroitin sulfate proteoglycan this was by transforming 
growth factors and transcription factors. This lead on to the improvement of the 
microenvironment for nerve growth. The study looked at joint inhibition of the 
intracellular and extracellular components of glial scar and specifically looked at 
curcumin which significantly reduced glial scar volume and improved locomotor rating 
and axon growth (Yuan et al., 2015).  
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Another study (Prasad, Gupta, Tyagi, & Aggarwal, 2014) also reviews the uses and 
benefits of curcumin also known as the golden spice. The history of this spice dates 
back thousands of years but only recently has the chemistry been studied (Prasad et 
al., 2014). The last two decades has seen more than 6000 articles that have been 
published which have discussed curcumins molecular basis of the antioxidant and 
anti-inflammatory properties. As well as multiple studies that lead on from this idea, 
clinical trials have also been conducted to see the effects of this on multiple chronic 
conditions. Because this study shows the use of anti-inflammatory properties, this 
promoted the need to investigate other compounds with anti-inflammatory properties 
(Prasad et al., 2014). 
As well as Curcumin, other studies have also used other compounds possessing anti-
inflammatory effects on the CNS. This adds to the argument that the glial scar formed 
in the CNS under trauma is brought about by inflammatory reactions of the immune 
system. Carvedilol is a beta blocker that treats congestive heart failure left ventricular 
dysfunction (LVD) and for treating high blood pressure. It has been examined to show 
how it promotes neurological function, reduces bone loss and attenuates cell damage 
after acute spinal cord injury. The results of this study indicate that carvedilol does 
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Table 1: Table showing various Anti-inflammatories ("Drugs to Treat Various Pain 
Conditions," 2016) 
Non-Steroidal Anti-Inflammatory drugs (NSAIDs) ("Drugs to Treat Various 
Pain Conditions," 2016) 














Treats pain associated 





Celecoxib (Celebrex) anti-inflammatory 
properties, treatment 




Treat muscle pain, 
back pain and various 
forms of arthritis  
Prescription and OTC (Dose 
dependant)  
Diclofenac sodium 
(Voltaren, Voltaren XR) 
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Diclofenac sodium with 
misoprostol (Arthrotec) 









Treats pains and fever, 
Anti-inflammatory  
Prescription  
Flurbiprofen (Ansaid) Treatment of joint 




Motrin, Motrin IB, 
Nuprin) 
Treatment of pain, 
Anti-inflammatory  









Select, Doan's Pills, 
Magan, Mobidin, 
Mobogesic) 
Treatment of joint 
stiffness, pain and 
swelling 
Prescription  











Anti-inflammatory  Prescription  
Meloxicam (Mobic) Treats osteoarthritus 
pain 
Prescription 






Treatment of pain, 
Anti-inflammatory 
 




Oxaprozin (Daypro) Treats arthritis, 
reduces pain, swelling 
and stiffness of joints. 
Prescription  
Piroxicam (Feldene) Treatment of pain, 
Anti-inflammatory 
Prescription and OTC (Dose 
dependant) 
Salsalate (Amigesic, 




reduces pain, swelling 
and stiffness of joints. 
Prescription 
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Sodium salicylate  Analgesic, antipyretic, 
induces apoptosis in 
cancer cells  
Prescription 
Sulindac (Clinoril) Treatment of pain, 
Anti-inflammatory 











Table 2: Showing natural anti-inflammatory remedies 
Natural anti-inflammatory remedies (Maroon, 2010) 
Ant-inflammatory  Effect 
Omega-3 EFAs (fish oil) Anti-inflammatory  
White willow bark Analgesic and antipyretic  
Curcumin (turmeric) antioxidant, anti-inflammatory, and 
antineoplastic 
Green tea  Anti-inflammatory and delays 
progressive joint space narrowing seen 
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1.1.4.2 In vitro models that demonstrate anti-inflammatory treatment of CNS 
inflammation  
 
In vitro can be translated to in glass and is related to studies that are in test tubes or 
petri dishes. An advantage of this type of model is that is yields specific results and 
has a species – species relationship. The methods used for in vitro studies are often 
simpler, more convenient and are more detailed than studies done by in vivo models.  
One disadvantage of in vitro models is that results can be difficult to extrapolate into 
in vivo models that is, how the whole organism might be affected. In vitro models are 
starting to replace studies that use whole animals.  
The central nervous system has a large cell population that is heterogeneous in nature 
and because of the cell population being so varied; it has inhibited the studying and 
describing biochemical characteristics of well-defined cell populations. The developing 
of a strategy or protocol to enable the isolating of cell populations into neurons, 
oligodendrocytes or astrocytes. This isolation of cells into a homogenous population 
has a variety of benefits. 
When looking at the adult brain, it is to be noted that CNS tissues contain a significant 
amount of myelin which can then make it difficult to isolate these microglial cells in a 
cell suspension. Myelin is a membrane that insulates axons in the peripheral and 
central nervous systems and the formation of myelin is continuous through life. Mice 
who are older will have higher levels of myelin, it is then imperative to remove myelin 
from the tissues cell suspension prior to cell sorting or staining to ensure clean cell 
fractions. 
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One method of isolating and analysing of mouse microglial cells is described a study 
(Garcia, Cardona, & Cardona, 2014). The study defines microglial cells as phagocytes 
that have one nuclease and they make up about 10% of the central nervous system. 
These cells survey and monitor neuronal tissue and are derived from myeloid 
progenitor cells, they play an important part in homeostasis, inflammatory and immune 
responses. This study describes multiple microglial cell isolation protocols (Garcia et 
al., 2014). 
Another study looks at in vitro models of glial scar inhibition and primarily investigates 
how astrocytes respond when the central nervous system is injured (Wanner et al., 
2008). The study looks at the role of reactive astrogliosis in relation to the formation of 
the glial scar (Wanner et al., 2008).  The proposed model in the study (Wanner et al., 
2008) combined two key aspects of CNS injury, mechanical trauma as well as co 
culture with meningeal cells.  
This provided a useful in vitro model of the scar from cultures that included highly 
differentiated astrocytes. To do the analysis, the morphology of cells was looked at for 
signs of astrocyte reactivity. The increase of markers like glial fibrillary acid protein 
(GFAP) and noting the expression levels of scar associated markers like phosphacan, 
neurocan and tenascins were also seen to be increased (Wanner et al., 2008). The 
model in this study provides a useful tool for investigating the underlying mechanisms 
of the glial scar formation and it is a useful model as it provides quantifiable inhibition 
of axonal regeneration (Wanner et al., 2008). 
A further protocol for the analysis of primary glial cells created a positive cell culture 
model which is ideal for the investigation into factors that form the glial scar (Polikov, 
Su, Ball, Hong, & Reichert, 2009).  After the isolation of glial cells for analysis, they 
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can be subjected to forms of stress, including oxidative stress however other stresses 
can be used that includes, metabolic stress as well as physical stress (Polikov et al., 
2009).  
 
1.1.4.3 In vivo models that demonstrate anti-inflammatory treatment of CNS 
inflammation  
 
In vivo models are models that are done within living animals. Advantages of in vivo 
models include observing the effects of study on the living subject. Clinical trials and 
animal testing are major in vivo elements. In vivo models are starting to replace human 
trials in more recent times. In vivo methods more specifically the use of transgenic and 
knockout animal models have been used in order to study inflammation, infection and 
autoimmune CNS diseases as well as the relationship between all three (Sohet, 
2013)..  
A study that used TNF-α transgenic mice showed that overexpression of TNF-α is 
sufficient enough for the mice to develop neurological disorders that have chronic CNS 
inflammation as well as white matter degeneration. One useful way to study microglia 
is by using rodent tissue for in vitro culturing. Though there are drawbacks such as 
yielding low numbers of cells and the methods used are often time consuming for using 
murine primary microglial culture. These drawbacks limit the types of studies that can 
be conducted on these cell types (Li, 2003). 
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1.1.4.4 Specific examination of anti-inflammatory compounds  
1.1.4.5 Kawakawa leave extract 
 
The Kawakawa plant or Macropiper excelsum (Forst. F.) Mig is a shrub that is found 
to be growing in shady areas near the coast throughout New Zealand. Kawakawa can 
be identified by its shiny green leaves and small yellow fruit and have been exploited 
by Maori for the shrubs significant healing properties. This shrub belongs to the family 
Piperaceae and is reported to have medicinal properties (Richardson, 2015) .   
This is a native plant found in coastal areas throughout New Zealand. Cuts, wounds, 
stomach pains and toothache have been reported to be cured by the KawaKawas leaf 
and bark. The smoke from the slow burning of Kawakawa leaves has on the other 
hand has been used as an insecticide (Richardson, 2015). Chromatography of 
extracts of the leaves gave an active fraction from which four neutral lignans have 
been isolated, one of which is diayangambin (Russell, 1973). 
Lignans are natural products that have a range of various biological activity. In the 
literature, many lignans are found in immunomodulatory, anti-allergic, and anti-
inflammatory activities by inhibiting T cell proliferation. Lignans can also inhibit multiple 
pro inflammatory mediators such as cytokines, eicosanoids and the platelet activating 
factor. In recent times, the furofuran lignin, diayangambin as well as other lignin 
derivatives have been isolated from leaves of Piper fimbriulatum C.D.C. These plants 
grow in Panama and belong to a large genus containing ca. 700 species. South 
American folk medicine use these plants for several purposes including inflammatory 
processes (Russell, 1973). 
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The data present in a study shows that diayangambin possesses in vitro modulatory 
activity on lymphocyte proliferation and PGE2 generation of macrophages. The way 
diayangambin modulates the responses of lymphocytes and macrophages might be a 
useful way to treat immune and inflammatory responses (Russell, 1973). 
Though little research has gone into the composition and biological activity of 
kawakawa there are two known bioactive molecules, myristicin and diayangambin 
which are found in the leaves of the plant (Richardson, 2015).   
Myristicin is the more common of the two bioactive molecules and it has been reported 
in other plant sources including nutmeg, parsley and dill. Myristicin has been well 
studied in terms of its biological activity which helps make evident the medicinal 
properties of kawakawa. As well as being an anti-inflammatory and an anti-microbial 
agent Myristicin has also been found to be hepatoprotective (Richardson, 2015). 
Myristicin is also a known psychoactive drug and precursor to the psychedelic drug 
MMDA. This transformation has been suggested by some to play a part during 
metabolism in the body.  As well the significant bioactivity held by myristicin, it has 
also been found to be an effective insecticide (Richardson, 2015).  
The other bioactive molecule in question is diayangambin. Diayangambin in 
comparison to myristicin is a rare product that also holds significant bioactivity. 
Diayangambin exhibits anti-inflammatory activity and is also an immunosuppressive 
agent. Drugs utilising diayangambin as an immunosuppressive agent have been used 
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1.1.5 Objectives and aims of our research  
 
The research topic in question for this project is titled “In vitro cell culture to study 
microglial inflammation” the aims for which include investigating novel compounds that 
could have anti-inflammatory effects on primary glial cell cultures.  We aim to 
investigate inflammation that is expressed by primary glial cells under trauma to the 
central nervous system (CNS). This project was inspired by an overseas conference 
where the glial scar and its components was discussed. The context of this project is 
put into focus with an understanding of how far research has advanced in relation to 
knowing more about the mechanisms involved in the inflammation of the CNS. 
Inflammation of primary glial cells cause’s problems for future CNS healing and 
treatments for how this could be treated or mitigated on some level is being examined. 
Our project uses three cell lines THP1, HeLa and an isolated primary glial cell cultures. 
These cell lines are used to investigate and demonstrate the effect Kawakawa leaf 
extracts have on these cell lines. An investigation into what effects Kawakawa leaf 
extract could have on primary glial cell inflammation. 
Given the above research into the literature, it is evident that there is a link between 
CNS trauma and an inflammatory reaction. The idea of applying novel or new 
compounds with anti-inflammatory properties is not new and has been done to varying 
degrees of success. Our research identifies the setting up a primary cell culture of glial 
cells using post mortem brain tissue from mice/rats. The approach we will take in 
addressing this issue, is by using novel compounds that have not been applied to 
primary glial cell cultures which includes the New Zealand Kawakawa plant. The novel 
compound we will be using in our study is extracts of Kawakawa leaves which are 
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extracted under two different temperature conditions. A further avenue for study could 
include the investigation of mitochondria in primary glial cell cultures.   
The overall in vitro primary glial cell model in mind for our study uses primary glial cell 
cultures from brains of mice or rats post mortem. The methodology that is used in our 
project is similar to that of other studies where we set up a primary glial cell culture 
and will confirm that this is a primary glial cell culture glial cell culture using 
immunocytochemistry. This method proves effective for isolation of primary glial cell 
cultures as seen in other studies.  
Our way of addressing this issue of CNS inflammation is by investigating modulators 
of primary glial cell inflammation. Primary microglial cell cultures will be taken from 
supplied mice/rat brains post mortem. The effects seen by novel or new anti-
inflammatory compounds will be monitored. Our research will use specific primers that 
will be used for detecting TNF-α levels and Inter leukin levels. The monitoring of the 
maturation of the glial cell culture can be done by using confocal microscopy and 
fluorescence microscopy. Microscopy will aid in observing proliferation of glial cells 
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2 Materials and Methods 
2.1.1 Growth assay  
HeLa and THP-1 cells were seeded at a density of x/ml into a 96 well tissue culture 
plate in a duplicate or triplicate fashion. The plate was incubated at 37OC in a humidity 
incubator (under standard incubating conditions). HeLa cells were harvested through 
days 1-5 by trypsinizing the cells and THP-1 cells were harvested through days 1-5 by 
centrifugation. Viable cells were counted using a haemocytometer.  
2.1.2 Cell cultures and dose response curves 
2.1.2.1 Cell Cultures 
2.1.2.2 HeLa and THP-1 cell culture: 
The human cervical cancer HeLa and THP-1 cell lines were borrowed from the 
University of Waikato’s stock of frozen cell samples. In order to grow a culture of HeLa 
cells, a frozen sample of HeLa cells were thawed in a water bath at 37OC. An aliquot 
of 1 ml of cells was grown in a T25 flask containing 4mls of complete growth media 
that was more specifically DMEM media (Gibco) that contained 10% foetal bovine 
serum (FBS). The cells were then incubated at 37OC in a 5% CO2 humidified incubator. 
After 1-2 days of incubation, the flask was checked under the microscope to observe 
the amount of confluency. If confluent, the cells were harvested to preform various 
experiments. Cells were harvested by decanting the flask of the complete growth 
media and washing the cells in 1ml of PBS. A 2 ml aliquot of trypsin/EDTA was added 
to lift the cells off the flask surface and into solution. To neutralise the trypsin EDTA, 
complete DMEM media should be added to the solution. The cell solution was then 
centrifuged (Megafuge 1.0) at 1100 rpm for 5 minutes. The supernatant was then 
discarded and the cell pellet was re-suspended in 2 mls of pre-warmed DMEM 
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complete growth media. It should be noted that the experiments carried out use 
exponentially growing cell cultures or near confluent cell vessels. 
The THP-1 cell line was borrowed from the University of Waikato’s stock of frozen cell 
samples. In order to grow a culture of THP-1 cells, a frozen sample of THP-1 cells 
were thawed in a water bath at 37OC. An aliquot of 1 ml of cells was grown in a T25 
flask containing 4mls of growth media that was more specifically DMEM media (Gibco) 
that was titled glutaMax. This was supplemented with 10% foetal bovine serum (FBS). 
The cells were then incubated at 37OC and 5% CO2 in a humidified incubator. After 1-
2 days of incubation, the flask was checked under the microscope to observe the 
amount of confluency. If confluent, the cells were harvested to preform various 
experiments. Cells were harvested by decanting the flask into a 15mL falcon tube. The 
cell solution was then centrifuged (Megafuge 1.0) at 1100 rpm for 5 minutes. The 
supernatant was then discarded and the cell pellet was suspended in 2 mls of 
glutaMax complete growth media. It should be noted that the experiments carried out 
use exponentially growing cell cultures or near confluent cell vessels. 
An alternative media to use for THP-1 cells consists of 0.5ml 100 mM Sodium 
pyruvate, 0.5ml 100x penicillin/ streptomycin, 5 mls of FBS and bring up to 50 mls with 
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2.1.3 Dose response curves  
 
Does response curves were generated over a 7 day period for HeLa and THP-1 cells. 
The HeLa cells were grown in complete DMEM media in 96 well plates. THP-1 cells 
were grown in full RPMI- Glutamax media or THP-1 media and were grown in 96 well 
plates. 
Does response treatments included KawaKawa leaf extracted from two conditions at 
60oC and room temperature see section 2.3 Kawakawa extract preparation.  
The cells were exposed to 100ug/ml, 50/ug/ml, 25/ug/ml, 12.5 ug/ml and 6.25 ug/ml 
concentration of both extracts. Each day two wells per extraction concentration was 
counted with a haemocytometer using trypan blue exclusion method. The two counts 
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2.2 Cytotoxicity assays  
2.2.1 Detection of Apoptosis in HeLa cells and THP-1 cells 
 
2.2.1.2 Introduction  
 
Cellular toxicity can be caused by either necrotic or apoptoic cell death. To study the 
cytotoxic effects of Kawakawa leave extracts on HeLa cells and THP-1 cells, typical 
characteristics of apoptosis and necrosis were examined using various biochemical 
techniques. One of the main characteristics of apoptosis includes the ability of the cell 
to maintain plasma membrane integrity after death. Biochemical assays like [3-(4,5- 
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) and lactate 
dehydrogenase (LDH) were conducted as well as trypan blue exclusion experiments. 
Visual characteristics such as morphological changes such as membrane formation 
and bubbling are seen as cells undergo apoptosis was also examined under the 
microscope.  
2.2.2  LDH Assay 
Lactate dehydrogenase (LDH) is a cytosolic enzyme that is released into growth media 
as a consequence of disruption to the plasma membrane which is used as a marker 
of necrotic cell death. The Promega CytoTox96 NonRadioactive Cytotoxicity Assay kit 
was used to determine the levels of LDH present in a solution. The experiment was 
carried out following the instructions based on the manufacturer’s protocol.  
Two 96 well plates’ were used and in one row each well contained 100ul of blank 
media (media containing no cells, such as PBS). Another row of wells contained 100ul 
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of cells in suspension and the last group of wells were inoculated with 100ul of 
disrupted cells on a separate plate. Plate one will have the blank media and intact cells 
and the second plate will have disrupted cells. It should be noted that all wells should 
be repeated in a duplicate or triplicate fashion. 
Plate one was incubated overnight in the 37OC CO2 incubator and plate two was 
placed in the -20OC freezer overnight. The next day, the plates were centrifuged at 
250g for 4 minutes. After which, 50ul of supernatant was transferred to new wells and 
50 ul of substrate solution was added to the supernatant.  
The plates were then incubated in standard incubating conditions for 30 mins. In order 
to stop this assay 50 ul of stop solution was added to each well and the plates were 
read by a Model 680 Microplate Reader (Bio-Rad) with an absorbance of 490nm. 
The LDH assay is used to obtain the percentage of LDH content in solution that is 
relative to the control. The data was averaged and then normalised by subtracting the 
averaged blank media reading. The maximum control was multiplied by 1.1 if need be 
to account for adding the lysis solution. The final data presented is a percentage which 
can be interpreted as the percentage of dead cells that are present in the original cell 
culture if we assume that all cells released equal amounts of LDH.  
 
 
         Cytotoxicity (%) = 100x 
                           
Equation 1: Calculating the percentage of relative cytotoxicity. 
 
(Experimental LDH release 
OD490) 
(Disrupted cells OD490) 
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2.2.3 MTT Assay  
 
MTT [3-(4,5-dimethylthialzol-2-yl)-2,5-diphenyl tetrazolium bromide] is a tetrazolium 
dye. When MTT is reduced by the cellular dehydrogenase, blue crystals are formed 
intracellularly. These crystals can then be dissolved and can also be quantified using 
spectrometry. The dissolving of the crystals can be an indication for mitochondrial 
dehydrogenase activity. 
The MTT Assay was carried out as per the manufacturer’s protocol. Control cells and 
test compounds with cells were prepared and were loaded onto a 96 well microplate 
having a 100ul/well final volume.  A volume of 10 ul of MTT at 4.5mg/ml concentration 
solution was added per well, achieving a final concentration of 0.45mg/ml. The 
microplate was incubated for 30 -45 minutes at 37OC. The incubation period was 
stopped when purple crystals were seen under the microscope. 
After the incubation period 100 ul of stop solution was added to the wells the plate was 
then placed on a minishaker for 10 minutes. Absorbance was then read at 570nm on 
a microplate reader. The data was averaged out where the average blank was 
subtracted from the other data conditions.  
 
Absorbance (corrected) = (Sample OD 570nm) – (Blank OD 570nm) 
 
Equation 2: Calculating the corrected MTT absorbance. 
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The obtained experimental data was normalised to the control and subsequently 




Equation 3: Calculating mitochondrial dehydrogenase activity. 
 
2.3 Kawakawa extract preparation  
 
The preparation of the Kawakawa leave extract was done by using three varying 
methods. The three methods were prepared at room temperature, at 60OC and 
prepared using a distillation kit.  
2.3.1 Method 1: Room temperature preparation of Kawakawa leaf extract 
 
Leaves from a Kawakawa tree were gathered and cut into small fragments where 10g 
of leaves was weighed out. The fragments were then added into a beaker of 60mls of 
distilled water. The solution was then stirred at room temperature using magnetic 
stirrers for 3 hours with a foil cover over the top of the beaker.  
2.3.2 Method 2: 60oC temperature preparation of Kawakawa leaf extract 
 
Like method 1, Leaves from a Kawakawa tree were gathered and cut into small 
fragments where 10g of leaves were weighed out. The fragments were then added 
Dehydrogenase activity (%) = 100% x 
Control sample absorbance (corrected) 
Experimental sample absorbance (corrected) 
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into a beaker of 60mls of distilled water. The solution was then stirred on a heat plate 
at 60C using magnetic stirrers for 3 hours with a foil cover over the top of the beaker.  
 
2.3.4 Freeze drying samples  
 
After the preparation of the kawakawa extracts the samples were then centrifuged for 
5 minutes at 1100rpm to settle the organic material in the sample. After this, 15mls of 
the liquid was then aliquoted into 50ml falcon tubes and labelled according to each 
experimental condition. These tubes were then frozen in liquid nitrogen which involved 
placing the tubes in liquid nitrogen at a relatively flat angle to ensure a thin surface 
area of frozen solution. Sample tubes were then rolled in the liquid nitrogen and once 
this was done to all tubes, they were then placed into large cylindrical flasks and put 
onto the freeze drier machine. This dried the samples over 1-2 days and produced a 
powder that could be reconstituted and used for experiments. An empty 50 ml falcon 
tube was weighed and this weight was zeroed after which all other tubes were 
weighed. The weights of each product was recorded and samples were then placed 
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2.4 Growth experiment exposing HeLa Cells to KawaKawa extracts 
2.4.1 Serial dilution for concentrations:  
 
The concentration of Kawakawa extracted wanted for the growth experiment was 
calculated using  
 
CI x VI = C2 x V2 
 
Equation 4: Showing the equation for working out relative concentrations 
Serial dilutions of Kawakawa leaf extracts were prepared and were used in growth 
experiments. The conditions room temperature and 60oC were used as these yielded 
the most extract once freeze dried. Approximately 0.02g of samples of each condition 
were reconstituted with 10mls of complete DMEM media which was then put through 
a syringe filter to decant the solution away from  excess organic material.  
The starting concentration was again to carry out a serial dilution is calculated by using 
Equation 4. 
Once this serial dilution has provided the needed concentration of the extract a growth 
experiment that uses a 96 well tissue culture plate was set up. The Rows A-D 
represented the day in this case, Row A is day 1, Row B is day 2, Row C is day 3 and 
Row D is day 4 and Row E is day 5 
The well numbers 1-6 represented the different concentrations with the exception of 
well 6 which was used as a control that has only cells with complete DMEM media.  
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One 96 well tissue culture plate was set up for the room temperature kawakawa 
extracts and another 96 tissue culture plate was set up for the 60oC temperature 
kawakawa extracts. 
The dose experiments were conducted over a five day period and with two cell lines 
HeLa cells and THP1 cell lines. These experiments were repeated in duplicates and 
were documented by pictures from wells under each day and condition and was further 
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3. Primary Glial Cell culture  
 
Primary glial cells were used in order to show the effect of the kawakawa leave extract 
on neuronal cell inflammation. To enhance the growth and proliferation of primary glial 
cells, the surface of the vessel that was used to grow the culture was coated with 
polylysine  
3.1 Polylysine coating: 
The procedure for coating a vessel with polylysine includes diluting 1 part stock 
solution with 19 parts of water to prepare a 50 g/ml working solution (105 ul stock and 
2mls distilled water into a flask). Once this solution is prepared the culture vessel 
surface was coated with 1.0ml of polylysine and rocked gently to ensure even coating 
of the surface. After 5 minutes the solution was removed and the vessel was rinsed 
with 2 mls of distilled water or PBS three times. The liquid was removed from the 
vessel and this was allowed to surface dry for at least 1 to 2 hours before inoculation 
with cell suspension.  
3.1.2 Glial cell isolation:  
Before starting the isolation procedure percoll solutions need to be made up 
3.1.3 To create a percoll gradient with a cell interphase: 
 
The molecular weight of NaCl is 58.46 which means 1M of NaCl solution is 58.46 g/L 
and to make 1.5M of NaCl solution 87.69 g/L. To make a 1.5M NaCl of 10 mls 0.8769 
g/10mls is added to 10mls of distilled water. To dilute this solution to 0.15M of NaCl 1 
ml of the 1.5M NaCl was added to 9mls of distilled water.    
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A 1.5M solution of NaCl was made up which is added to percoll at a ratio of 1:9 that is 
1ml of 1.5M NaCl and 9mls of percoll. This solution is known as stock isotonic percoll 
(SIP) as the NaCl makes the percoll isotonic. In order to make further dilutions of this 
isotonic solution the 0.15M NaCl was used. To make 10mls of 100% percoll, or SIP 
mix 9mls of percoll and 1ml of 1.5M NaCl. To make 10mls of 70% percoll, mix 7mls of 
SIP and 3mls of 0.15M NaCl. 
In order to culture primary glial cells, fresh brain tissue was needed from mice or rats 
and the procedure for the removal of the brain tissue as well the procedure for isolating 
primary glial cells can be found below.  
 
3.2 Brain removal 
 
The head was removed from the body and a midline incision was made in the skin and 
the skin was then flipped over the eyes to free the skull. A small incision was made 
going from the top of the skull right down towards the eyes. Taking note that a firm cut 
through the most anterior part of the skull needs to be made. The parietal bone on 
both sides as well as the frontal bone was broken off. The brain was then free from 
the meninges and to do this slide the forceps under the anterior part of the brain and 
slip the brain upward. The forceps were slipped under to further break the optic nerves 
and cranial nerves and the brain was gently lifted out of the skull. The brain was then 
transferred to a petri dish that was on ice to cool the brain down and any excess 
material was washed off in sterile PBS.  
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3.3 Primary glial cell isolation procedures  
3.3.1 Primary glial cell isolation procedure using percoll  
 
The brain was carefully removed from the skull as mentioned in section 3.2 brain 
removal. The brain was then transferred to a petri dish and was washed with sterile 
PBS (the tissue was kept in a petri dish on ice). The tissue from the brain was then 
homogenized. The cell mix was then transferred to a 15ml falcon tube and made up 
to 7 mls of complete DMEM growth media.  Then 3ml of 100% percoll solution was 
added to the cell suspension and was mixed by inversion. The solution was then 
transferred to a 15ml tube containing 2ml of 70% percoll solution (The glial cells will 
lay atop the 70% layer of percoll).  
This tube was then centrifuged for 30 minutes at 550x g at 18oC after which the debris 
was removed from the top by pipetting. The interphase that contains the mononuclear 
cells should be located just above the 2ml graduation of the 15ml tube. The interphase 
(2ml) was then transferred to a 15ml tube containing 8ml of PBS to wash the cells of 
the percoll and this was mixed by inverting. The tube was centrifuged for 7 minutes at 
900 G at 4oC. 
The supernatant was discarded and the cell pellet was suspended in 2ml complete 
growth media. A syringe filter was used to filter the solution and a flask was inoculated 
with 1 ml of cell suspension and 4 mls of complete growth media. Incubate at 37oC in 
CO2 conditions (standard incubation conditions)  
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3.3.2 Primary glial cell isolation procedure using histopague  
 
An alternative method for glial cell isolation using histopaque and not polylysine was 
also carried. This procedure involved euthanizing a rat where the head was disinfected 
in 70% ethanol. The rats brain was removed from the skull and placed in a petri dish 
where it was washed in sterile PBS. The brain tissue was homogenized and was 
transferred to a tube containing 4 mls of complete DMEM media. This solution was 
added as a layer on top of 3mls of histapaque in another centrifuge tube and was then 
centrifuged at 400g for 30-40 minutes at 18oC.  
The top layer after centrifugation was removed which exposed the mononuclear cell 
layer which is a cloudy white layer. This layer was then transferred to a sterile tube 
and washed with 8 mls of PBS. The cells were suspended into solution by gently 
pipetting the solution up and down. The tube was then centrifuged at 400-500g for 10-
15 mins at 18oC and the supernatent was removed after centrifugation. The cell pellet 
was then suspended in 8mls of PBS and centrifuged at 400-500g for 10 mins. After 
this final cell wash the supernatant was removed and the cell pellet was suspended in 
DMEM complete media with strep b antibiotic.  
The growth of a primary glial cell culture was documented by pictures and once a 
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4.5 Other methods 
4.5.1 To split and harvest cells: 
 
Cells should be harvested to perform experiments on or cell splitting is needed when 
the initial flask is confluent to prevent cell apoptosis. An initial cell count when splitting 
and harvesting cells is essential to ensure the cell number is known. If a suspension 
cell line such as THP-1, cells were harvested from the inoculated vessel by 
centrifuging the cells for 5 mins at 1100 rpm. The cell pellet was then suspended in 2 
mls of complete growth media. A cell count was performed to work out how many cells 
are needed to inoculate the new vessel. These new vessels were then inoculated with 
1ml of cell solution at a desired number and 4 mls of complete growth media.  
Please note, if using an adherent cell line such as HeLa cells, preliminary steps of 
washing the cells with PBS and adding TE to lift the cells of the vessel is required.   
4.5.2 To freeze cells down: 
 
To freeze cells down each cryogenic tube has a 1ml capacity and a cell count is done 
when freeing down cells to ensure the cell number is known. Cells were harvested as 
in section to split and harvest cells 4.5.1 and 950ul of cell solution and 50ul of 100% 
DMSO was added to cryogenic tube. DMSO is an agent that prevents cells dying from 
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4.6 Reagents and media recipes: 
 
Table 3: Showing recipes of media and reagents used. 
Name Composition 
Phosphate-buffered saline (PBS) NaCl 8g/L (137mM) 
KCL 0.2 g/L (2.7 mM) 
Na2HPO4 1.42 g/L (10 mM) 
KH2PO4 0.25 g/L (1.8 mM) 
800 mls of distilled water to dissolve 
salts 
HCL to adjust pH to 7.4 
Top up to 1 litre with distilled water 
 
Complete Growth Media (with glucose) 5mls of FBS 
45mls of DMEM (with glucose) 
1.5 M Tris- HCL, pH 8.8 Dissolve 181.65g Tris base in 800 mL of 
ddH2O 
Adjust pH to 8.8 with concentrated HCL 
Bring volume to 1 litre with ddH2O 
0.5 M Tris- HCL, pH 6.8 Dissolve 181.65g Tris base in 700 mL of 
ddH2O 
Adjust pH to 6.8 with concentrated HCL 
Bring volume to 1 litre with ddH2O 
10% Sodium Dodecyl Sulfate (SDS) 5g SDS 
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Make up to 50mL with ddH2O water 
Acrylamide-bis stock  
Ammonium persulphate 0.05 grams of ammonium persulphate 
0.5 mls of distilled water 
TEMED  
Trypsin EDTA For 100 mls 10x Trpsin - EDTA: 
0.5g of trypsin power 
80 ml of distilled water 
10 ml of 10X PBS 
0.5 ml of EDTA solution 
Adjust to 100ml with distilled water 
 
1X Solution 
Take 1 ml of solution and mix with 9ml 
of PBS 
Tryptophan Blue  
Fetal Bovine Soltion (FBS)  
MTT solution 0.005g of MTT 
Dissolve in 1 ml of PBS 
BCA stock solution 20 mg of BSA 
10 ml of PBS 
BCA working reagent (WR) BCA Reagent A  50 parts 
BCA Reagent B 1 part : Ratio of 50:1 
5x Electrode buffer 15g Tris (124mM) 
72g glycine (959mM) 
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50mL of 10% SDS (0.5%) 
Ponceau S. 1g of Ponceau S 
50ml acetic acid 
Make to 1 litre with distilled water 
Mammalian Protein Extraction Reagent 
(m-PER reagent) 
 
Dimethyl sulfoxide (DMSO) 0.25M EDTA pH 7.5 
20%DMSO 
Comassie blue stain 200mls methane 
50mls acetic acid 
250 mls distilled water 
0.1g per 100mls of brilliant blue (0.5g) 
Destainer 400 mL methanol (40%) 
100mL Acetic acid (10%) 
500mL of ddH2O 
NaCl NaCl MW = 58.46 
1000mls of NaCl 1.5M = 87.69 
10mls of NaCl 1.5M = 0.8769g/10mls 
10mls of NaCl 0.15M = 1ml of NaCl 
1.5M 9mls of distilled water 
Percoll To make 100% (SIP) solution of percoll 
mix 9mls of percoll and 1 ml of 1.5 NaCl 
to a tube 
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To make a 70% solution of percoll mix 
7mls of SIP and 3mls of 0.15 NaCl to a 
tube. 
 
TBS-Tween(TBST) 100mL 10x TBS 
0.5mL Tween20 (0.05%) 
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4.7 Statistical Analysis  
 
The statistics used for this study was carried out in Microsoft Excel. The data was 
averaged if appropriate and the standard error of the mean (S.E.M) was calculated by 
finding the standard deviation of the samples, finding the square root of the sample 
number and subsequently dividing both numbers  
    
 
 













SQRT (sample number) 
S.E.M  = 





5.1 Cell Culture and Dose Response Curves  
 
HeLa and THP-1 cells were seeded at a density of 7,000 cells/ml onto a 96 well plate 
containing complete DMEM and THP-1 media respectively in duplicates. The two 
plates were then placed under standard incubation conditions and the cell number 
estimated using the tryphan blue dye exclusion assay every 24 hours.  
To determine the growth rate of HeLa and THP-1 cells under standard incubation 
conditions, a standard growth curve was plotted (figure 1). The HeLa growth curve 
showed that the cells remained in a lag-phase during days 1-4, entering the 
exponential growth phase at day five.  The experiment had an N=1 and the error 
bars represent (±SEM) of cell counts from two wells. 
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5.2 Cell Culture and Dose Response Curves  
 
Kawakawa extracts were prepared at 60OC and room temperature described in 
section 2.3 Kawakawa extract preparation.  
HeLa and THP-1 cells were seeded at a density of 7,000 cells/ml onto a 96 well plate 
containing complete DMEM media and THP-1 media, respectively. The cells were 
then exposed to Kawakawa extracts at various concentration in duplicates. The two 
plates were placed in standard incubation conditions and the cell number was 
estimated using the tryphan blue exclusion method every 24 hours.    
5.3 Dose Response of HeLa cells when exposed to Kawakawa extracts 
 
HeLa cells were used as they are a robust cell laboratory cell line, cell culture 
techniques and methods can be easily carried out on this cell line. HeLa Cells were 
exposed to varying concentrations of Kawakawa extracts prepared at room 
temperature or 60oC.  
The growth rate of HeLa cells exposed to room temperature Kawakawa extracts at 
varying concentrations over a 5 day period is shown in Figure 2. HeLa cells treated 
with kawakawa extracts and the untreated control cells exhibited a lag-phase during 
days 1-4 (similar to that described earlier). Interestingly, the kawakawa extract 
concentrations (6.25, 12.5, 25 and 50 µg/ml) led to a marked inhibition of cell growth 
during day 4-5 compared to the untreated control cells, which had entered the 
exponential growth phase during this period. Cells exposed to the highest Kawakawa 
extract concentration of 100µg/ml had however, entered an exponential growth 
phase, at a much reduced growth rate when compared to the control cells. This 
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Figure 2: Showing room temperature dose curves of HeLa cells. Error bars show the 
S.E.M. 
 
The growth rate of HeLa cells exposed to 60OC Kawakawa extracts at varying 
concentrations over a 5 day period is shown in Figure 3. HeLa cells treated with 
kawakawa extracts and the untreated control cells exhibited a lag-phase during days 
1-4 (similar to that described earlier). Interestingly, the kawakawa extract 
concentrations (6.25 and 25 µg/ml) led to a marked stimulation of cell growth during 
day 4-5 compared to the untreated control cells.  The Kawakawa extract 
concentration (12.5, 50 and 100µg/ml) led to a marked inhibition of cell growth during 
































Figure 3:  HeLa cell growth exposed to various concentrations of 60oC Kawakawa 
extract. Error bars showing S.E.M. 
 
To compare cell growth across treatments the rate of cell growth was calculated 
during the exponential growth phase between days 4 and 5. The slopes for HeLa 
cells exposed to 60OC Kawakawa extract concentrations were taken from the graph 
over this time period and shown in figure 4. The slopes for HeLa cells exposed to 
room temperature Kawakawa extract concentrations were taken from the graph over 
the same time period and is shown in figure 5. The gradient of the lines of best fit for 
HeLa cells at 60OC are expressed in table 4. The gradient of the lines of best fit for 
HeLa cells at room temperature are expressed in table 5.  
 
The degree of growth rate inhibition was then determined as shown in figure 6. 
Strong growth inhibition was exhibited by HeLa cells treated with room temperature 
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96.7%, 85.5%,102%). Slight growth inhibition was exhibited by HeLa cells treated 
with 100 ug/ml concentration (51%) as shown in figure 6.  
Strong growth inhibition was exhibited by HeLa cells treated with 60OC Kawakawa 
leave extracts at concentrations 12.5 and 100 ug/ml (71.1% and 75%). Weak growth 
inhibition was exhibited by HeLa cells treated with 100 ug/ml concentration (75.5%). 
Interestingly, strong growth stimulation was exhibited by HeLa cells treated with 
60OC kawakawa leave extract 25 ug/ml (91.1%). Slight growth stimulation was 
exhibited by HeLa cells treated with 6.25 ug/ml (25.5%) as shown in figure 6.      
 
 

































Figure 5: Cell growth of HeLa cells exposed to room temperature Kawakawa extract 
with lines of best fit. 
 
Table 4: Gradients of lines of best fit from Figure 13 relative to control. 
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Table 5: Gradients of lines of best fit from Figure 14 relative to control. 
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5.4 Dose Response of THP-1 cells when exposed to Kawakawa extracts 
 
THP-1 cells were used as they are a cell line that can elicit an inflammatory reaction 
when exposed to LPS. THP-1 cells were exposed to varying concentrations of 
Kawakawa extracts prepared at room temperature or 60oC.  
The growth rate of THP-1 cells exposed to room temperature Kawakawa extracts at 
varying concentrations over a 5 day period is shown in Figure 7. THP-1 cells treated 
with kawakawa extracts and the untreated control cells exhibited a lag-phase during 
days 1-4. The kawakawa extract concentration (12.5, 25, 50 and 100 µg/ml) led to a 
marked inhibition of cell growth during day 4-5 compared to the untreated control 
cells, which had entered the exponential growth phase during this period. The 
kawakawa extract concentration (6.25 µg/ml) led to a marked stimulation of cell 
growth during day 4-5 compared to the untreated control cells. This experiment had 
an N=1 and the error bars represent (±SEM) of cell counts from two wells. 
 
Figure 7: THP-1 cell growth exposed to various concentrations of room temperature 
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The growth rate of THP-1 cells exposed to 60OC Kawakawa extract at varying 
concentrations over a 5 day period is shown in Figure 8. THP-1 cells treated with 
kawakawa extracts and the untreated control cells exhibited a lag-phase during days 
1-4. The kawakawa extract concentration (6.25 12.5 and 100 µg/ml) led to a marked 
inhibition of cell growth during day 4-5 compared to the untreated control cells, which 
had entered the exponential growth phase during this period. The kawakawa extract 
concentration (25 µg/ml) led to a marked stimulation of cell growth during day 4-5 








Figure 8: THP-1 cell growth exposed to various concentrations of 60OC Kawakawa 
extract. Error bars showing S.E.M. 
To compare cell growth across treatments the rate of cell growth was calculated 
during the exponential growth phase between days 4 and 5. The slopes for THP-1 
cells exposed to 60OC Kawakawa extract concentrations were taken from the graph 


























Julia Newland 1107101  
 
78 
room temperature Kawakawa extract concentrations were taken from the graph over 
the same time period as shown in figure 10. The gradients of the lines of best fit for 
THP-1 cells at 60OC are expressed in table 6. The gradients of the lines of best fit for 
THP-1 cells at room temperature are expressed in table 7.  
The degree of growth rate inhibition was then determined as shown in figure 11. 
Strong growth inhibition was seen on THP-1 cells treated with 60OC Kawakawa 
leave extracts at concentrations of 6.25, 12.5 and 100 ug/ml (45.5%, 47.3% and 
81.1%). Weak growth inhibition was seen on THP-1 cells treated with 50 ug/ml 
(4.0%) as seen in figure 11.  
Interestingly, strong growth stimulation was seen on THP-1 cells treated with 60OC 
kawakawa leave extracts 25 ug/ml (39.8%). Slight growth stimulation was seen on 
THP-1 cells treated with room temperature Kawakawa leave extracts at the 
concentration 6.25 ug/ml (22.3%) as seen in figure 11.      
Strong growth inhibition was seen on THP-1 cells treated with room temperature 
Kawakawa leave extracts at concentrations 12.5, 25, 50 and 100 ug/ml (62.2%, 
103.2%, 70.8%, 94.3%) as seen in figure 11.  
 









Figure 10: Cell growth of THP-1 cells exposed to room temperature Kawakawa 
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Table 6: Gradients of lines of best fit from Figure 18 relative to control. 








Table 7: Gradients of lines of best fit from Figure 19 relative to control. 
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5.5. Discussion  
 
The objective of this section was to assess the effect of Kawakawa leave extracts 
had on the growth of HeLa and THP-1 cells. HeLa and THP-1 cells were incubated 
with a range of Kawakawa leave extract concentrations, producing both inhibitory 
and stimulatory effects on cell growth as seen in figure 6 and figure 11.  
The main findings this study found was that kawakawa extracts exhibited both 
stimulatory and inhibitory effects on cell cultures.  
Various bioactive compounds such as diayangambin, excelsin, epiexcelsin, 
Myristicin and demethoxyexcelsin have been isolated from kawakawa leaves. Figure 
12 shows the chemical structures of Myristicin and Diayangambin. (Richardson, 
2015; Russell, 1973). 
 
Figure 12: Chemical structures of Myristicin and Diayangambin 
 
In the literature myristicin has been shown to be hepatoprotective. Alanine 
aminotransferase (ALT) and asparate aminotransferase (AST) are typical markers of 
liver damage. The levels of the activities for these markers were suppressed by 
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myristicin at 50, 100 or 200 mg/kg in mice having liver injury induced by LPS (Morita, 
2003). As myristicin is a biomolecule found in kawakawa leave extract, this might be 
the reason for the increase in cell growth seen in figure 6 and figure 11. 
In the literature, myristicin has also been found to display apoptotic activity in human 
leukaemia K562 cells. Apoptotic activity can been characterised by changes in 
mitochondrial membrane potential, chytochrome c release,  caspase- 3 activation, 
PARP- cleavage and DNA fragmentation (Martins, 2014). 
One of the early features of the intrinsic apoptotic pathway is the dissipation of the 
mitochondrial transmembrane potential which then leads to the release of 
cytochrome-c. Cytochrome c is thought to be a prominent pro-apoptotic signalling 
protein that is released from the mitochondria (Martins, 2014). 
The bioactive compounds noted above were not isolated and identified in this study. 
Further characterisation of the compounds present in kawakawa extracts at room 
temperature and 60OC need to be undertaken.   
The results presented here are n=1 and because of this, dose response experiments 
need to be repeated to determine the validity of trends and reproducibility.  
In order to determine if the growth inhibition of the kawakawa extracts was due to 
either necrotic or apoptotic processes, LDH and MTT assays were undertaken as 
described in section 5.6 Effects of kawakawa extracts on HeLa and THP-1 cell 




Julia Newland 1107101  
 
84 
5.6 Effects of Kawakawa extracts on HeLa and THP-1 cell function  
 
Since some of the Kawakawa extracts were shown to be inhibitory to cell growth it 
was decided to see if this inhibition was due to necrotic cell death. To help illustrate 
the functioning of cells exposed to treatment biochemical assays are used.  
Lactate dehydrogenase (LDH) is a strict intracellular enzyme that is only released 
into the media when the cellular membrane ruptures. The LDH assay was used to 
determine if the cytotoxicity of kawakawa leave extracts on HeLa and THP-1 cells 
was due necrotic cell death.  
5.7 Results  
5.7.1 LDH Assays 
 
The percentage of lysed cells was worked out by dividing the experimental samples 
with the maximum release of cells (this was obtained by freezing the cells overnight 
at -20OC) shown by equation 1 in section 2.2.2 LDH assay. The THP-1 cells without 
extracts (control sample) had 37.2% lysed cells and was not significantly different 
from the 6.25 and 100 ug/ml room temperature kawakawa extract groups which had 
35.61 and 36.93% of lysed cells.  However, treatment with 12.5, 25 and 50 ug/ml 
room temperature kawakawa extract resulted in decreased percentage of lysed cells 
compared to the control (28.4, 32.7 and 30.7 %) shown in figure 13. 
The THP-1 cells without extracts (control sample) had 37.2% lysed cells and was not 
significantly different from the 50 and 100 ug/ml 60OC kawakawa extract groups which 
had 33.74 and 34.02% of lysed cells.  Treatment with 6.25, 12.5 and 25 ug/ml 60OC 
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kawakawa extract resulted in a slightly decreased percentage of lysed cells compared 
to the control (32.8, 32.4 and 30.74 %) shown in figure 13. This experiment had an 
N=1 and the error bars represent (±SEM) of cell counts from two wells. 
 
 
Figure 13: Showing the percentage of lysed THP-1 cells after 48 hours. Error bars 
show S.E.M. 
 
The HeLa cells without extracts (control sample) had 75.86% lysed cells, because of 
the high level of dead cells in the control the results are difficult to interpret. The 
treatment with 6.25, 12.5, 25 and 100 ug/ml room temperature kawakawa extract 
resulted in decreased percentage of lysed cells compared to the control ( 74.04, 
72.18, 74.53 and 74.93 %) shown in figure 14. Treatment with 50 ug/ml room 
temperature kawakawa extract resulted in increased percentage of lysed cells 
compared to the control (78.73 %) shown in figure 14. This experiment had an N=1 
and the error bars represent (±SEM) of cell counts from two wells. 
The control sample had 75.86% lysed cells and was not significantly different from 
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of lysed cells.  However, treatment with 50 ug/ml 60OC kawakawa extract resulted in 
decreased percentage of lysed cells compared to the control (71.3%) shown in figure 
14. Interestingly, treatment with 25 and 100 ug/ml 60OC kawakawa extract resulted 
in a slight increase in percentage of lysed cells when compared to the control (77.19 
and 78.48%). 
 
Figure 14: Showing the percentage of lysed HeLa cells (%) after 48 hours. Error bars 
show S.E.M. 
 
The LDH assay detects how intact the cellular membrane is by measuring the 
release of the cytosolic enzyme LDH into extracellular space detected when the cell 
membrane is no longer intact and is ruptured. The LDH assay involves the 
enzymatic conversion of a tetrazolium salt, INT [2-(4-iodophenyl)-3-(4-nitrophenyl)-5- 
phenyl-2H-tetrazolium chloride], into a water soluble red formazan product. As this is 
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The LDH assay showed that, THP-1 cells treated with 60OC and room temperature 
Kawakawa leave extracts compared to the control sample did not have increases of 
cell lysis after 48 hours. This data suggests that cellular death is not caused by 
necrosis mechanisms. However different growth rates are seen on HeLa cells and 
THP-1 cells exposed to various kawakawa extracts, an exponential growth phase is 
observed between days 4 and 5 see figure 2, figure 3, figure 7 and figure 8. LDH 
needs to be repeated at this time period.   
 
5.7.2 MTT Assays  
 
Given that cell growth inhibition was unlikely to be due to necrosis (see LDH data) it 
was decided to see if cell death was caused by mitochondrial processes that would 
further support apoptotic cell death. The biochemical assay MTT was used to 
indirectly measure mitochondrial dehydrogenase activity in the presence of 
kawakawa leave extracts. 
For each day of the five-day experiment, HeLa cells and THP-1 cells were incubated 
with MTT for 45 minutes to 1 hr. After this time, the formazan crystals were 
solubilised, the absorbance was read and the results were presented as a 
percentage of mitochondrial dehydrogenase activity that was then compared to the 
control samples. Particular interest was in the MTT results seen at day 5 as this was 
when the cells entered the exponential phase. 
THP-1 cells that are not exposed to kawakawa extract (the control) are assumed to 
demonstrate maximum mitochondrial activity (100%). Treatment with 50 and 100 
ug/ml room temperature kawakawa extract resulted in decreased percentage of 
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mitochondrial activity compared to the control (90.23 and 85.0 %) shown in figure 15. 
Treatment with 12.5 and 25 ug/ml room temperature kawakawa extract resulted in 
significantly increased percentage of mitochondrial activity compared to the control 
(140.8% and 104.02 %) shown in figure 15. This experiment had an N=1 and the 
error bars represent (±SEM) of cell counts from two wells. 
The control THP-1 cells was not largely different from the 100 ug/ml 60OC kawakawa 
extract which had 92% of mitochondrial activity.  However, treatment with 6.25, 12.5, 
25 and 50 ug/ml 60OC kawakawa extract resulted in decreased percentage of 
mitochondrial activity compared to the control (78.3, 73.0, 72.12 and 79.65%) shown 
in figure 15. 
 
Figure 15: Shows the average percentage of mitochondrial dehydrogenase (%) 
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HeLa cells that have not been exposed to kawakawa extracts (the control) 
demonstrate mitochondrial activity of 100%, when compared to treatment with 12.5, 
25, 50 and 100 ug/ml room temperature kawakawa extract resulted in slight 
decreased percentage of mitochondrial activity compared to the control ( 97.5, 98.7, 
98.7 and 96.97%) shown in figure 16. Treatment with 6.25 ug/ml room temperature 
kawakawa extract resulted in a percentage of mitochondrial activity comparable to 
the control (100.53 %) shown in figure 16.  
Treatment of HeLa cells with 6.25, 12.5, 25 and 50 ug/ml 60OC kawakawa extract 
resulted in decreased percentage of mitochondrial activity compared to the control 
(96.4, 97.8, 98.7 and 99.5%) shown in figure 25. Treatment with 100 ug/ml 60OC 
kawakawa extract resulted in an increased percentage of mitochondrial activity 
compared to the control (109.17 %) shown in figure 16.  
 
 
Figure 16: Shows the average percentage of mitochondrial dehydrogenase (%) 
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The control THP-1 sample when compared to treatment with 6.25 ug/ml room 
temperature kawakawa extract resulted in decreased percentage of mitochondrial 
activity compared to the control ( 95.86% ) shown in figure 17. Treatment with 12.5, 
25, 50 and 100 ug/ml room temperature kawakawa extract resulted in an increased 
percentage of mitochondrial activity compared to the control (107.76, 103.11, 102.6 
and 102%) shown in figure 26.  
Treatment with 6.25, 12.5, 25 and 50 ug/ml 60OC kawakawa extract resulted in 
decreased percentage of mitochondrial activity compared to the control (90.42, 
88.89, 90.89 and 93.85%) shown in figure 17. Treatment with 100 ug/ml 60OC 
kawakawa extract resulted in a percentage of mitochondrial activity comparable to 
the control (99.4%) shown in figure 17. This experiment had an N=1 and the error 
bars represent (±SEM) of cell counts from two wells. 
 
 
Figure 17: Showing the average mitochondrial dehydrogenase activity produced over 
5 days by THP-1 cells when exposed to varying Kawakawa extract concentrations. 
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The control sample for HeLa cells when compared to treatment with 6.25, 12.5, 25, 
50 and 100 ug/ml room temperature kawakawa extract resulted in an increased 
percentage of mitochondrial activity (106.5, 106, 105.4 105.4 and 102.5%) shown in 
figure 18.  
Treatment with 6.25 and 12.5ug/ml 60OC kawakawa extract resulted in decreased 
percentage of mitochondrial activity compared to the control (98.1% and 98%) 
shown in figure 18. Treatment with 50 ug/ml 60OC kawakawa extract resulted in a 
percentage of mitochondrial activity comparable to the control (100%) shown in 
figure 18.  Treatment with 25 and 100 ug/ml 60OC kawakawa extract resulted in an 
increased percentage of mitochondrial activity when compared to the control (101 
and 102%) shown in figure 18. 
 
 
Figure 18: Showing the average mitochondrial dehydrogenase activity produced over 
5 days by HeLa cells when exposed to varying Kawakawa extract concentrations. 
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To determine if the Kawakawa leave extracts had any effects on mitochondrial 
function, the MTT assay was used. This cell viability assay measures the reduction 
of MTT (a water-soluble tetrazolium dye) to formazan crystals that are insoluble. This 
reduction reaction relies on activity from living cells and their activity of functioning 
mitochondrial dehydrogenase. Therefore the MTT assay is an indicator of cell 
viability as well as mitochondrial activity.   
The MTT assay showed that THP-1 cells treated with 60OC and room temperature 
Kawakawa leaf extracts for five days led to increases and decreases in the average 
mitochondrial dehydrogenase activity. Treatment of THP-1 cells with 12.5 ug/ml 
room temperature kawakawa extract produced an increase in mitochondrial 
dehydrogenase activity when compared to the control and other treatments. 
Treatment of THP-1 cells with 100 ug/ml room temperature kawakawa extract 
produced a decrease in mitochondrial dehydrogenase activity when compared to the 
control and other treatments. Treatment of THP-1 cells with 60OC kawakawa extract 
produced decreases in mitochondrial dehydrogenase activity when compared to the 
control. Treatment of THP-1 cells with 25 ug/ml 60OC kawakawa extract produced 
the largest decrease in mitochondrial dehydrogenase activity when compared to the 
control and other treatments. Treatment of THP-1 cells with 100 ug/ml 60OC 
kawakawa extract produced mitochondrial dehydrogenase activity comparable to or 
similar to the control. 
MTT data for HeLa cells exposed to 60OC and room temperature Kawakawa leave 
extracts for five days led to increases and decreases in the average mitochondrial 
dehydrogenase activity. Treatment of HeLa cells with 6.25 ug/ml room temperature 
kawakawa extract produced mitochondrial dehydrogenase activity similar to and 
comparable to the control. Treatment of HeLa cells with 12.5 ug/ml, 25 ug/ml 50 
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ug/ml and100 ug/ml room temperature kawakawa extract produced a decrease in 
mitochondrial dehydrogenase activity when compared to the control. Treatment of 
HeLa cells with 60OC kawakawa extract produced decreases in mitochondrial 
dehydrogenase activity when compared to the control. Treatment of HeLa cells with 
6.25 ug/ml 60OC kawakawa extract produced the largest decrease in mitochondrial 
dehydrogenase activity when compared to the control and other treatments. 
Treatment of HeLa cells with 100 ug/ml 60OC kawakawa extract increased 
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6 General discussion and future perspectives   
 
One of the objectives in this study was to investigate the effects kawakawa leaf 
extracts had on cellular inflammation. However, before this could be achieved, 
preliminary experiments were conducted to find out if the extract was cytotoxic to 
mammalian cells. 
Two main cell lines were used in this study, HeLa and THP-1 cell lines. HeLa cell 
lines are a standard laboratory cell line that has a quick culture time, this cell line is 
robust and many laboratory experiments can easily be carried out on the cells. THP-
1 cells were used due to their inflammatory reaction with lipopolysaccharide (LPS). 
LPs is an endotoxin that is from gram negative bacteria and it is known to elicit a 
strong immune response. An inflammatory reaction via the TLR receptors in THP-1 
cells can be induced by LPS allowing experiments to be run to monitor potential anti-
inflammatory effects of compounds. LPS induces pro-inflammatory markers such as 
cytokines IL-6 and TNFa (Huber, 2001). LPS and kawakawa extracts at various 
concentrations were exposed to cell cultures were they would be incubated for at 
standard incubating conditions.  
The objective of the section 5.6 Effects of Kawakawa extracts on HeLa and THP-1 
cell function was to assess the cytotoxicity that was induced by the Kawakawa leaf 
extract against HeLa and THP-1 cell lines. Cell growth data with both THP-1 and 
HeLa cells indicated that kawakawa leaf extracts were cytotoxic at different 
concentrations. 
To assess the mechanism of cell death cytotoxicity assays like LDH and MTT were 
carried out to determine whether HeLa cells and THP-1 cells undergo apoptosis or 
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necrosis when exposed to kawakawa leaf extracts. The LDH assay is a colourmetric 
assay which detects membrane integrity by measuring the amount of cytosolic 
enzyme LDH released by the cells upon cell lysis. The LDH assay involves 
enzymatic conversion a tetrazolium salt, INT [2-(4-iodophenyl)-3-(4-nitrophenyl)-5- 
phenyl-2H-tetrazolium chloride], into a water-soluble red formazan product. The 
amount colour seen is proportional to the amount of cell lysis. 
The most interesting finding of this study is when kawakawa extracts inhibit cell 
growth there is no increase in LDH. This is suggestive that the cellular membrane 
remains intact when exposed to the extract. The treatment of HeLa cells produced a 
more variable LDH dataset when compared to the dataset of THP-1 cells.   
When comparing the LDH dataset with day two of the dose response curve of THP-1 
cells there appears to be a slight correlation. As cell numbers increase, the LDH data 
decreases and as the cell numbers decrease, the LDH data increases. This 
correlation is better seen on THP-1 cells exposed to kawakawa extracts prepared at 
room temperature, see figure 16 and figure 23.  
However as the HeLa cells without treatment expressed a high level of LDH the 
results are difficult to interpret, see Figure 24. One reason for this high level of LDH 
in the control might be attributed by mycoplasma contamination. Mycoplasma are 
small bacteria that are parasitic belonging to the class molicute; there are more than 
180 species and they infect a large range of hosts. Mycoplasma contamination is 
one of the biggest issues in cellular research which does not often result in cellular 
death but it can be responsible for multiple effects seen in cultured cells. Such 
effects are seen to alter the cells’ metabolism including slowed proliferation. This 
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might also be a reason that an abnormally long lag phase was observed in HeLa 
dose response curves. See figures 11 and 12. 
Mycoplasma contamination is difficult to detect and could compromise the accuracy 
of the data produced by infected cell lines. It can be detected via PCR that uses 
primers specific to mycoplasma which can then be amplified and loaded on to a gel 
(Dobrovolny, 2011; Olarerin-George, 2015).   
The dose response curves and the LDH data did not strictly correlate which suggests 
that the membrane of the cells was intact and cell death was not due to necrosis. As 
cell death was unlikely to be due to necrosis, it was important to find out if the 
inhibition of cell growth was due to impaired mitochondrial activity. There was 
because of this, MTT assays were conducted to assess the mitochondrial activity of 
the cells. When cell number does not correlate with the increase of the MTT dataset 
this may suggest that the extract might increase mitochondrial activity and cellular 
metabolism without directly effecting cell number.  
The MTT assay was used to measure the reduction of MTT, a water soluble 
tetrazolium dye, to insoluble formazan crystals.  This reduction is dependent on the 
function of cellular dehydrogenases in living cells hence this assay is also an 
indicator of cell viability and mitochondria activity.  
When comparing the MTT datasets and the dose response curves for THP-1 cell line 
there does not seem to be any correlation as cell numbers increase the 
mitochondrial activity decreases and because of this a correlation cannot be made. 
See figures 16, 17, 24 and 26. 
The MTT datasets for HeLa cell lines exposed to 60OC kawakawa extract are similar 
to the THP-1 cell line and a correlation cannot be made. See figures 11, 12, and 27. 
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Though the dataset for HeLa cells exposed to room temperature kawakawa extract 
shows some decreases in MTT activity when cell numbers decrease. See figure 11, 
12, 25 and 27. 
The presented MTT data shows the effects the kawakawa leaf extract had on 
mitochondrial activity. In order to fully demonstrate cell death by apoptosis, hallmark 
characteristics need to be measured. These include cytochrome C release, DNA 
laddering and caspase activation. 
The dataset in this study is preliminary, and suggests that the kawakawa leaf extract 
can be both cytotoxic and provide growth stimulation. This is the first study to 
document such results. 
However, the limitations of the dataset in this study is that the results are based on 
n=1 and in order to validate this studies results, repetition of the experiments is 
needed.  
In order to investigate the anti-inflammatory properties of the kawakawa leaf extract, 
it is needed to demonstrate that agents like LPS are able to elicit and inflammatory 
response from THP-1 cells. THP-1 cells are a transformed cell line, and because of 
this, the inflammation reaction seen in THP-1 cells may not mirror inflammatory 
responses seen in primary microglial cells.    
Because of this, it was decided that primary microglial cells would be isolated from 
rodent brain tissue. An attempt to isolate primary microglial cells was made so that 
experiments concerning the anti-inflammatory properties of kawakawa leaf extracts 
can be conducted.  
In the future, experiments conducted in this study such as dose response curves, 
MTT and LDH need to be repeated in order to validate the results. Another future 
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objective is to isolate the bioactive molecules within the kawakawa leaf and address 
the anti-inflammatory properties of the extract by conducting RNA isolation and 
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6.1 Glial cell isolation  
 
An objective of this study was to isolate and induce inflammation using LPS on 
primary microglial cells and to have an in vitro model set up to see how the 
kawakawa extracts modulate the inflammatory process.   
A challenge to overcome when culturing primary microglial cells is avoiding bacterial 
contamination. Brain tissue was obtained from rats post mortem and it was important 
to avoid contamination. To overcome this issue, all equipment was autoclaved, the 
media and reagents used in this study was sterilised by using syringe filters and 
gloves were worn at all times.    
Another challenge to overcome when culturing primary microglial cells is growing an 
adherent and viable cell culture. To overcome this issue, the vessels used to culture 
these cells were coated with polylysine. As primary microglial cells are an adherent 
cell line, they attach better when grown in vessels that are coated. Polylysine is used 
to coat cell culturing vessels and it acts as an attachment factor that improves cell 
adherence. It does this because of the interaction of the positively charged polymer 
and negatively charged cells. 
Primary microglial cells were used as these are central nervous system cells that are 
involved in numerous neurodegenerative diseases and inflammation pathways.  
After overcoming the challenges a stable culture from rat brain tissue was 
established. Figure 19 shows cells that are dendritic, elongated in shape and 
adherent to the culture vessel; these cells were isolated in vitro. The method for 
isolating primary glial cells is seen in chapter 3.  
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After carrying out this procedure two things were altered, instead of making the initial 
suspension up to 7mls of completed growth media, this volume was brought down to 
5mls. The other thing that was altered was increasing the amount of 70% percoll that 
was used was increased from 2mls to 4mls. These alterations were because of low 
yields of tissuel that was used in this study. 
It is also important to identify the neuronal phenotype of the cells using antibodies 
such as CD11b/c. CD11b/c is found on chromosome 16 and is able to bind to all 









In order to determine if the isolated cell culture in figure 28 contained primary 
microglial cells identification of the cells needs to be carried out via 
Immunocytochemistry (ICC). ICC involves fixing the cells to the slide, permeabilize 
these cells and incubate the slide and cells with the primary antibody followed by the 
secondary antibody. Stain the slide with DAPI and view the slide under florescent 
microscopy.  
  
Figure 19: Showing cells isolated from a rat brain 
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To address the anti-inflammatory properties of kawakawa leaf extracts on primary 
microglial cells, these cells would need to be exposed to both the extract and LPS. 
After 24 hours of exposing cells to LPS, RNA is needed to be extracted from the 
cultured cells. If good quality RNA is extracted (proven by running on an 
electrophoresis gel and nano drop results), the RNA would then be converted to 
cDNA via rt-PCR. A rt-PCR reaction with TNFa and IL-6 primers would be conducted 
and the product would then be run on an electrophoresis gel to compare band sizes. 
Experiments like western blotting can also be conducted in order to examine the 
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